- Report
- November 2021
- 1184 Pages
Global
From €5700EUR$6,000USD£4,903GBP
- Report
- August 2023
- 110 Pages
Global
From €3392EUR$3,570USD£2,918GBP
- Report
- April 2023
- 147 Pages
Global
From €5699EUR$5,999USD£4,903GBP
- Book
- October 2013
- 488 Pages
- Book
- December 2023
- 208 Pages
- Book
- January 2022
- 720 Pages
- Book
- October 2020
- 288 Pages
- Book
- May 2023
- 1104 Pages
The Exosome market is a subset of the biotechnology industry that focuses on the development of exosome-based therapeutics. Exosomes are small vesicles that are released by cells and contain proteins, lipids, and nucleic acids. They are involved in a variety of biological processes, including cell-to-cell communication, and have been shown to have potential therapeutic applications. Exosome-based therapeutics are being developed to treat a range of diseases, including cancer, neurological disorders, and cardiovascular diseases.
Exosome-based therapeutics are still in the early stages of development, but the potential of these treatments has attracted the attention of many biotechnology companies. Some of the companies in the Exosome market include Exosome Diagnostics, Exosome Sciences, Exosome Technologies, Exosome Therapeutics, and Exosome Sciences. Show Less Read more